维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Formann"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Sonar tracking of multiple targets using joint probabilistic data association显示文摘	Formann TE Bar-Shalom Y Scheffe M	1983	IEEE Journal of Oceanic Engineering1983，8，3：	1
	2	Sonar tracking of multi- ple targets using joint probabilistic data association显示文摘	Formann T E Bar-Shalom Y Scheffe M	1983	IEEE Jour- nal of Oceanic Engineering1983，8，3：	1
	3	Mozart effect–Shmozart effect: A meta-analysis显示文摘	Jakob Pietschnig Martin Voracek Anton K. Formann	2010	Intelligence2010，，3：	1
	4	Prospective study of viral clearance and CD4 + T-cell response in acute hepatitis C primary infection and reinfection显示文摘	Judith H. Aberle Elisabeth Formann Petra Steindl-Munda Lukas Weseslindtner Calin Gurguta Gabriela Perstinger Evelyn Grilnberger Hermann Laferl Hans P. Dienes Theresia Popow-Kraupp Peter Ferenci Heidemarie Holzmann	2006	Journal of Clinical Virology2006，，1：	1
	5	Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin显示文摘	Formann E Stauber R Denk D M	2004	Ame J Gastroenterology2004，99，5：	1
	6	Plasma 25-hydroxyvitamin Dlevels and risk of incident hypertension显示文摘	Formann JP Giovannucci E Holmes MD	2007	Hypertension2007，49，：	1
	7	Twice-weekly administration of peginterferon α-2b improves viral kinetics in patients with chronic hepatitis C genotype l显示文摘	Formann E Jessner W Bennefl L	2003	J Viral hepat2003，10，4：	1
	8	Severe skin reac-tions duing therapy for chronic hepatitis C associated with de-layed hypersensitivity to pegylated intefferons显示文摘	Jessner Kinaciyan T Formann E et a1	2002	Hepatolo-gy2002，36，4：	1
	9	Sonar tracking of multiple target using joint probabilistic data association 显示文摘	Formann T E Bar-Shalom Scheffe	1983	IEEE Journal of Oceanic Engineering1983，8，3：	1
	10	Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection显示文摘	Aberle JH Formann E Steindl-Munda P	2006	J Clin Virol2006，36，1：	1
	11	Humor styles and their re- lationship to explicit and implicit self-esteem显示文摘	Stieger S Formann AK Burger C	2011	Pers Individ Dif2011，50，5：	1
	12	Cloning and expression of flavones synthaseⅡfrom Gerbera hybrids显示文摘	Martens S Formann G	1999	The Plant Journal1999，20，5：	1
	13	干扰素α-2a加利巴韦林联用或不用金刚烷胺对慢性丙型肝炎病毒基因1型感染者的治疗:一项随机、双盲、安慰剂对照研究显示文摘Background/Aims: Amantadine may augment virological response rates to interferon-based therapy in chronic hepatitis C patients. Using a novel design, amantadine was studied in na ve genotype 1 patients treated in combination with peginterferon alfa-2a (40KD)/ribavirin. Methods: Patients enrolled in this randomized, placeo-controlled multicenter trial were stratified by single-dose interferon sensitivity (stratum I, 24 h HCV-RNA decline >1.4log 10; II, 0.8-1.39log10; III, < 0.8log10; a reliable means of identifying nonresponders to interferon/ribavirin) and fibrosis grade (F0/1/2 vs. F3/4) at baseline. All patients received peginterferon alfa-2a (40KD) 180 μ g/week plus ribavirin 1000-1200 mg/day and were randomized to receive amantadine 100 mg twice daily (N=114) or placebo (N=95) for 48 weeks. Results: Week 24 virological response rates in strata II and III, the primary outcome, were similar in patients treated with amantadine (63.7% ) or placebo (65.7% ), as were sustained virological response rates at week 72 (46.5 and 51.6% , respectively). Adverse event profiles were similar and amantadine did not improve health-related quality of life compared with placebo. Interferon sensitivity was the only significant predictor of treatment outcome. Conclusions: Adding amantadine to peginterferon alfa-2a (40KD)/ribavirin combination therapy does not augment virological response rates in genotype 1 patients. Virological response was almost exclusively determined by interferon sensitivity at baseline.	Ferenci P. Formann E. Laferl H. 刘丽娜	2006	世界核心医学期刊文摘(胃肠病学分册)2006，2，5：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费